Weedstocks Newswire Feed
Cannabis company executives share vision, answer questions live at VirtualInvestorConferences.com
NEW YORK, Sept. 6, 2018 /CNW/ -- VirtualinvestorConferences.com and KCSA Strategic Communications today announced the agenda for the upcoming VirtualInvestorConferences.com, the evergreen online investor conference series. Individual investors, institutional investors, advisors, and analysts are invited. The show opens at 9:45 AM ET, with the first live webcast at 10:00 AM ET, on Wednesday, September 12th.
REGISTER NOW: https://tinyurl.com/912CannabisVIC
Pre-registration is suggested to save time: There is no fee for anyone to log-in, attend the live presentations and ask questions.
September 12th Agenda
Self-Serve Delivery System for Canadian and Global Cannabis Market Data
TORONTO, Sept. 6, 2018 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC, Frankfurt: 3CM), a leading business technology company in the cannabis space, is pleased to announce it has established an industry framework for data reporting and analytics for the Canadian and global cannabis marketplace. Data and information captured through Cannvas.me, a global cannabis education platform, will be presented through a self-serve delivery system with innovative forms of information filtering and processing for enhanced insight and decision making.
"By leveraging our knowledge of advanced technology and consumer marketing we have created the tools to provide stakeholders in the Canadian and global cannabis market with the ability for evidence-based decision making," said Shawn Moniz, Chief Executive Officer, Cannvas MedTech. "The cannabis industry is in the very early stage of development and is lacking a central database for researchers, healthcare professionals, licensed producers and other industry stakeholders to gain access to real industry insights. Cannvas Data will produce data analytics and trend analysis on global consumer data and cannabis industry benchmarks. Data points such as consumption, health and wellness, demographics and geo-location are examples of what will be captured and analyzed for the multiple integrated verticals of the cannabis industry, empowering decision making with accurate, timely and insightful results."
Data is a major priority for corporations of all sizes. By using advanced technology, machine learning algorithms and artificial intelligence, Cannvas Data will analyze the large data sets captured from Cannvas.me online platform. The data originating from Cannvas.me, clinical and academic research, government reports and other sources will contain a broad spectrum of data points types, that when analyzed will uncover market trend, hidden patterns, unknown correlations, customer preferences and other valuable business information.
About Cannvas Data Cannvas Data is pioneering to be the census data of the cannabis industry by leveraging advanced technology, machine learning algorithms and scientific and medical research data to provide meaningful insights to the global cannabis community. Operating as part of the Cannvas.me platform, Cannvas Data analyzes a multitude of data points captured from those usering medical and recreational cannabis to improve their health and wellness. The platform is LP/REC agnostic which means it is not biased by the personal drivers of any one company or institution, and it is continuously evolving and adapting to users and recognizing and learning from changing trends. For more information visit: www.cannvasdata.com
Namaste Announces Exclusive Co-Supply, Marketing and Distribution Agreement With Leading Pre-Filled Vaporizer Company Airo Brands
VANCOUVER, Sept. 6, 2018 /CNW/ - Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV: N)(FRA: M5BQ)(OTCMKTS: NXTTF) is pleased to announce that the Company has signed an exclusive co-supply, marketing, and distribution agreement (the "Agreement") with Airo Brands Inc. ("Airo Brands" or "airo-vapor.com") to launch Airo Brands' pre-filled vaporizer cartridge brand in both the recreational and medical cannabis markets throughout Canada. As part of the arrangement, Namaste will produce and distribute Airo Brand's pre-filled vaporizer cartridges through the Company's wholly-owned subsidiary and Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR") Licensed Producer, Cannmart Inc. ("Cannmart").
This Agreement represents a strategic partnership between Namaste and Airo Brands to leverage Namaste's resources and Airo Brands established product, brand image and reputation. Through Infinite Labz, Namaste believes it has the capacity to become the "go to" service provider in this high growth, high margin market of pre-filled cartridges. Namaste's investment in Infinite Labz Inc. ("Infinite Labz"), which is a purpose-built facility for producing cannabis oil under the ACMPR regulations is located directly across the street from Cannmart. Infinite Labz will provide oil production services that will provide supply for Airo Brands' and other products which Namaste will bring to the online medical and recreational markets. To be partnering with one of the leading US-based producer of pre-filled vaporizers further validates Namaste's strategy and is a monumental step forward for the Company. Namaste plans to work with Airo Brands to exclusively source the highest quality cannabis oil and to facilitate production, packaging and distribution through Cannmart.
With the impending roll-out of recreational cannabis in Canada, the Company believes that over time the commoditization of cannabis will require companies to become more innovative in branding and marketing to differentiate themselves. Namaste is uniquely positioned with its Cannmart sales license to facilitate the production of unique, value-added products including Airo Brands vaporizer cartridges and pens, as well as other well-known brands like Lowell Smokes, California's leading pre-rolled brand, who Namaste has also partnered with to expand into the Canadian market. Namaste will continue to pursue strategic partnerships where the Company can leverage their e-commerce and technology platform to provide value to brands like Airo Brands.
Airo Brands is dedicated to perfecting the union between technology and personal vaporizers. Airo Brands is one of the fastest growing brands in the US with products sold in five states and in 800 physical locations. The market for pre-filled vaporizers has expanded rapidly in the US, and while Canadian's anticipate expansion of the legal medical and recreational cannabis platforms to include a wider offering of product categories, Namaste has positioned itself to leverage its ACMPR license, technology and background in the vaporizer industry to bring Airo Brands' products into the Canadian marketplace
As Namaste's strategy to become Canada's leading online retailer of all things cannabis unfolds, the Company is focused on providing consumers with the best possible choices of cannabis products available on the market. Cannmart's platform, which has been designed as a comprehensive cannabis marketplace, will offer patients the largest and most diverse offering of products including cannabis flower, oil, vaporizer pens and pre-filled cartridges along with pre-rolls and many other products as they become available in the medical and recreational markets.
humble+fume Signs Supply Agreement with the OCS to Supply 68 Products for Ontario's Adult-use Cannabis Market
TORONTO, Sept. 5, 2018 /CNW/ - humble+fume, Canada's leading distributor of cannabis accessories, is pleased to announce that it has entered into a supply agreement with the Ontario Cannabis Store (OCS) to provide 68 of the highest-quality cannabis accessories for sale online in Ontario.
"We are delighted that the OCS has put their confidence in humble+fume and will offer such an extensive selection of accessories from our catalog of leading brands," said Rob Morrell, Head of Commercial Operations at humble+fume. "With the OCS being the sole online vendor of cannabis in Ontario, this announcement secures another important building block for us, as it strengthens our leadership position as Canada's 'One Stop Shop' for cannabis accessories."
Under the terms of the agreement, humble+fume will supply 68 products for the OCS online, that beginning October 17, 2018, will be sold alongside a wide variety of cannabis products. humble+fume will also have the opportunity to introduce additional accessories in future product calls. The 68 products awarded were selected from humble+fume's product categories "Prepare, Consume, and Preserve" and included grinders, vaporizers, pipes, and responsible storage.
Morrell added, "humble+fume's agreement with the OCS signals continued momentum for our business. Ontario is expected to be account for almost 40% of cannabis-related sales in Canada. To have earned such a significant number of product listings illustrates the combined value we deliver to dispensaries of all sizes, with our unrivaled portfolio of products, our insight based solutions, and our industry-leading service."
To learn more about the humble+fume approach and their catalog, "50 Essential Cannabis Accessories for Dispensaries", go to their website www.humbleandfume.com.
Riposte Capital Calls on Leading Cannabis Licensed Producer, HEXO Corp., to Initiate a Review of Strategic Alternatives
Despite Enviable Assets, Contracts and Strong Balance Sheet, HEXO Trades at Deep Discount
Riposte Looks Forward to a Dialogue Leading to Constructive Action
NEW YORK, Sept. 6, 2018 /CNW/ -- Riposte Capital, LLC, the second largest public shareholder of HEXO Corp. ("HEXO"), a leading Canadian cannabis Licensed Producer (formerly called Hydropothecary Corp.), has sent the following letter from Khaled Beydoun, Riposte Capital's Managing Partner and Portfolio Manager, and Ryan Price, a Partner and the firm's Director of Research, to HEXO's Chief Executive Officer and Board of Directors:
VIA ELECTRONIC AND OVERNIGHT MAIL
September 5, 2018
/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES/
VANCOUVER, Sept. 6, 2018 /CNW/ - Koios Beverage Corp. (CSE: KBEV)(OTC: KBEVF) (the "Company" or "Koios") today unveiled the Company's plans to market its line of cannabis and CBD-infused beverages through an innovative distribution model, generally known as Direct Store Delivery (DSD) and Direct to Customer (D2C) sales.
Cannabis beverages are produced and distributed through the Company's wholly owned subsidiary, Cannavated Beverage Corp. in partnership with Keef Brands.
Direct Store Delivery involves selling and shipping directly to retail stores that carry Koios products, with no use of any independent third party – neither an independent wholesaler, nor the retailer's own warehouses.
"We're a company that thrives on innovation, and we're not afraid to do things differently when it makes sense to do so," said Koios CEO Chris Miller. "Building out distribution partnerships takes a lot of time and a lot of money, and adds additional cost to your products as you pay the middleman.
OTTAWA, Sept. 6, 2018 /CNW Telbec/ - LiveWell Canada Inc. ("LiveWell" or the "Company"), (TSXV: LVWL), announces that it has closed a non-brokered private placement of 3,992,000 units at a price of CAD$1.25 per Unit (the "Issue Price") for total gross proceeds of $4,990,000.
Each Unit will consist of one common share of the Company (a "Common Share") and one common share purchase warrant of the Company (a "Warrant"). Each Warrant shall be exercisable into one Common Share at a price of $1.50 per Warrant for a period of 24 months from the date of closing. If the volume weighted average price of the Common Shares on the TSX Venture Exchange is equal to or greater than $2.00 for any 10 consecutive trading days, the Company may accelerate the expiry date of the Warrants to the date that is 180 days following the date of such written notice.
The Company intends to use the net proceeds of the Offering for working capital and general corporate purposes.
All securities issued will be subject to a four month hold period. A total of $141,000 in finder fees is payable under this Offering.
About LiveWell Canada LiveWell Canada Inc. (TSX-V:LVWL) is an innovative Canadian company planning to become a leader in a new approach to health and wellness by conducting advanced studies on cannabidiol (CBD) and other cannabinoids in its world-class Research and Innovation Centre located in Litchfield, Québec. The company's mission also includes developing and distributing prescription and consumer health products. With more than 1.5 million square feet of greenhouses under construction located in Ontario and Québec, the company is supported by renowned academic and business partners such as Canopy Growth (TSX:WEED, NYSE:CGC) and Canopy Rivers. For more information, visit livewellcorp.com
Aphria completes divestment of all U.S. cannabis assets with sale of remaining interest in Liberty Health Sciences
Aphria clears balance sheet of U.S. cannabis investments and will reenter U.S. market when U.S. federal laws permit
LEAMINGTON, ON, Sept. 6, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has entered into a share purchase agreement with a group of buyers, each acting individually and not in concert, including a member of the Serruya family, and has completed the sale of 64,118,462 shares (the "Shares") in Liberty Health Sciences, Inc. ("Liberty"), representing 100% of the Company's outstanding investment in Liberty. As part of the transaction, Aphria retains an irrevocable option to repurchase the Shares or any replacement securities from the buyers for a period of up to five years, subject to the satisfaction of certain conditions as further described below. As a result of the transaction, Aphria has divested its remaining U.S. cannabis assets from its balance sheet in accordance with the staff notice and requirements of the Toronto Stock Exchange ("TSX"). As a result of this divestiture, the Company has significantly improved its liquidity position while it continues to focus on the many opportunities within Canada and in other legal cannabis markets around the world.
"Given the current federal legal framework in the United States, we have made the strategic decision to divest our remaining U.S. holdings at this time in order to permit us to focus on other more immediate capital markets and strategic opportunities in Canada and in other legal markets around the world," said Vic Neufeld, Chief Executive Officer of Aphria. "Not only does this transaction result in a significant gain to the Company it also enables Aphria to advance its existing global strategic plan unencumbered by U.S. exposure at this time."
"We view this decision as only a temporary departure from investment in the U.S. cannabis industry until such time as U.S. federal cannabis laws are reformed," continued Neufeld. "We have always believed in the tremendous opportunity in the U.S. cannabis market, and that is no different today. We intend to be a significant player in the U.S. cannabis industry at the appropriate time in the future and, in the interim, we look forward to watching our strategic partner Liberty continue to execute on the many opportunities emerging today."
The buyers of the Shares are purchasing 64,118,462 Shares of Liberty in exchange for a five-year promissory note due September 6, 2023 bearing interest at 12% per annum, in the amount of $59,097,986. Until such time as the promissory note is repaid, the Shares of Liberty or any replacement securities will be held in an escrow account by an independent escrow agent as security for the obligations under the promissory note. In the event of a default under the promissory note, the Shares or other replacement securities will be released from escrow by the escrow agent and sold with the net proceeds being paid to Aphria.
SMITHS FALLS, ON and TORONTO, Sept. 5, 2018 /CNW/ - Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NYSE: CGC) and Hiku Brands Company Ltd. ("Hiku") (CSE: HIKU) (together, the "Companies") are pleased to announce the closing of the previously announced acquisition of Hiku by Canopy Growth (the "Transaction").
Today's announcement follows Hiku's special meeting of shareholders held on August 30, 2018 where holders of the common shares of Hiku (the "Hiku Shares") voted to approve the Transaction.
"Leaves begin to turn. Canopy adds bold new brands. Ready for retail," commented Bruce Linton, Chairman & Co-CEO, Canopy Growth. "The Tweed and Vert brands we've built are now complemented with the likes of DOJA, Tokyo Smoke, Maitri, and Van der Pop, placing the taste-makers of tomorrow's cannabis industry on the same team."
"Since day one we've believed in a singular vision – that recreational cannabis is a consumer product and that consumers will ultimately choose brands they identify with from exceptional retail environments," said Alan Gertner, CEO, Hiku. "Today is a pivotal moment in our journey as it represents the chance to tell our story on the biggest stage with the greatest cannabis company the world has ever seen. We could not be more honoured to bring best in class brands and retail to consumers alongside Canopy Growth."
As a result of the Transaction, Hiku has become a wholly-owned subsidiary of Canopy Growth and the Hiku Shares are anticipated to be de-listed from the Canadian Securities Exchange on September 6, 2018. Trading of the Hiku Shares was halted on the Canadian Securities Exchange as of noon on August 31, 2018. Pursuant to the Transaction, Canopy Growth acquired 100% of the issued and outstanding common shares of Hiku and Hiku shareholders are entitled to receive 0.046 of a Canopy Growth common share in exchange for each Hiku Share held immediately prior to the closing.
Liberty Health Sciences Experiences Significant Growth In Florida Market, Largest Revenue Increase In Company History
TORONTO, Sept. 6, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high quality cannabis, announced today that they experienced a 95% increase in sales revenue in the three-month period ended August 31, 2018 compared to the previous three-month period which ended May 31, 2018.
Liberty's recent quarterly revenue totalled $2.2 million compared to $1.1 million for the previous quarter, a 95% increase. The growth in revenue reflects the wider recognition of the Liberty brands in terms of quality and consistency as well as the patient-centric approach that the Company uses. The corresponding patient count increased to almost 10,000 patients at the end of August from 4,600 at the end of May, a 112% increase over this time period.
"We are proud of our operational successes and as we move into the next quarter and we will focus on continuing to lead the way in the legal cannabis space with our portfolio of high-quality cannabis products, all while increasing shareholder value," said George Scorsis, CEO of Liberty Health Sciences. "Liberty will remain committed to diversifying and adapting to the ever-changing cannabis market, and we are looking forward to expanding our operations across the state of Florida and beyond."
Further adding to the revenue growth is the expanding footprint in the state. The Company operates four dispensaries currently as well as six delivery hubs. Liberty has also signed seven new leases for dispensaries that are at various stages of permitting and construction. These new locations are expected to be opened by the end of February 2019, subject to the receipt of necessary approvals from the Florida Department of Health. The recently announced expansion of its one-day delivery services and the 24-hour or less turnaround throughout the entire state of Florida has also had a favorable impact on patient and revenue growth.
"Liberty is well positioned to continue investing in infrastructure, along with R&D and future genetic study programs," said Scorsis. "Our team of people include some of the best in the industry and the Company will continue to drive further cutting-edge initiatives."